Aflac Incorporated: EPS $2.43 vs $1.80 expected; revenue $3.27B vs $4.12B
Key Facts
Q3 FY2026 results
| Metric | Actual | Estimate | Surprise | Year ago |
|---|---|---|---|---|
| EPS (USD) | 2.43 | 1.80 | +35.0% | 2.49 |
| Revenue (USD bn) | 3.27 | 4.12 | −20.6% | 4.79 |
Recent reports: actual vs estimate
| Reported | Period | EPS (USD) | Estimate | Surprise | Revenue (USD bn) | Estimate | Surprise |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Q3 FY2026 | 2.43 | 1.80 | +35.0% | 3.27 | 4.12 | −20.6% |
| Aug 6, 2026 | Q2 FY2026 | 1.75 | 1.76 | −0.6% | 4.12 | 4.14 | −0.6% |
| Apr 29, 2026 | Q1 FY2026 | 1.75 | 1.79 | −2.2% | 4.35 | 4.20 | +3.4% |
| Feb 4, 2026 | Q4 FY2025 | 1.57 | 1.69 | −7.1% | 4.87 | 4.25 | +14.5% |
| Nov 4, 2025 | Q3 FY2025 | 2.49 | 1.77 | +40.7% | 4.79 | 4.37 | +9.8% |
| Aug 5, 2025 | Q2 FY2025 | 1.78 | 1.70 | +4.7% | 4.22 | 4.33 | −2.6% |
| Apr 30, 2025 | Q1 FY2025 | 1.66 | 1.67 | −0.6% | 3.45 | 4.28 | −19.3% |
| Feb 5, 2025 | Q4 FY2024 | 1.56 | 1.62 | −3.7% | 5.50 | 4.33 | — |
Source: Figures from the EL7 database. Estimates are the analyst consensus carried by our data vendor (FMP), not official figures.
Aflac Incorporated results: EPS $2.43 vs $1.80 expected; revenue $3.27B vs $4.12B. The results cover the company's Q3 FY2026. EPS came in above analysts' estimate by 35.0%; revenue below the estimate by 20.6%.
Revenue was down 31.8% from $4.79 billion a year earlier (Q3 FY2025). EPS was down 2.4% from $2.49 a year earlier. On its record, EPS topped analysts' estimates in 2 of 7 earlier comparable reports.
What the results mean
Aflac’s business centers on supplemental health and life insurance in Japan and the United States. Its business drivers include the mix of coverage it sells, from cancer and medical expenses to accidents, disability and hospital stays, and how those products serve customer needs.
The product mix differs across these markets. In Japan, the business includes care coverage and savings-oriented insurance products, while the American business also offers dental, vision and critical illness coverage. Distribution relies on sales associates, brokers and agencies, making the effectiveness of these channels central to understanding business performance.
What to watch on the earnings call: Demand for health coverage and life insurance in Japan and the United States, the role of savings-oriented products and care coverage in the Japanese business mix, the effectiveness of sales associates, brokers and agencies in distributing policies, and management’s discussion of differences in customer needs across these markets.
For the full analysis of Aflac Incorporated stock — valuation, scores and financial statements — see the stock page linked with this story.